NCT06338358 Understanding Participation Habits Among Plaque Psoriasis Patients Status NOT_YET_RECRUITING Phase N/A
NCT06278350 Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT06220604 A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06176768 A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT06143878 A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06143371 A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. Status COMPLETED Phase PHASE1
NCT06122649 A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO) Status COMPLETED Phase PHASE3
NCT06108544 A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Status COMPLETED Phase PHASE3
NCT06106230 Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint Status COMPLETED Phase NA
NCT06104644 A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06095115 A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06095102 A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06088199 A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06088043 A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment Status COMPLETED Phase PHASE3
NCT06058546 Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis Status RECRUITING Phase PHASE2
NCT06030076 A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis Status RECRUITING Phase N/A
NCT06005532 Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® Status RECRUITING Phase PHASE3
NCT05994976 Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers Status RECRUITING Phase N/A